• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种低分子量丝氨酸蛋白酶抑制剂(抑肽酶)对分离脂肪细胞脂肪分解的影响。

Influence of a low molecular weight serine proteinase inhibitor (camostate) on lipolysis of isolated adipocytes.

作者信息

Göke B, Göke R, Lankisch P G

出版信息

Res Exp Med (Berl). 1985;185(6):503-7. doi: 10.1007/BF01851856.

DOI:10.1007/BF01851856
PMID:4089316
Abstract

The effect of the epsilon-guanidino acid derivate camostate (FOY 305) on lipolysis of isolated adipocytes was evaluated to test its supposed influence on the reactions of lipid metabolism in experimental shock. Isoprenaline (10(-6) M) and theophylline (10(-3) M) significantly stimulated lipolysis in vitro. The basal submaximal (isoprenaline 10(-6)-10(-9) M) and maximal (isoprenaline 10(-6) M) catecholamine-stimulated lipolysis were not affected by camostate (10(-6) M). Furthermore, camostate (0.1-100 X 10(-6) M) did not influence half-maximal theophylline-induced lipolysis of the adipocytes. Our findings do not support the suggestion that epsilon-guanidino acid derivatives diminish in shock the increase of free fatty acids in blood via an influence on lipolysis in the peripheral adipose tissue.

摘要

评估了ε-胍基酸衍生物卡莫司他(FOY 305)对分离的脂肪细胞脂解作用的影响,以测试其对实验性休克中脂质代谢反应的假定影响。异丙肾上腺素(10⁻⁶ M)和茶碱(10⁻³ M)在体外显著刺激脂解。卡莫司他(10⁻⁶ M)不影响基础次最大(异丙肾上腺素10⁻⁶ - 10⁻⁹ M)和最大(异丙肾上腺素10⁻⁶ M)儿茶酚胺刺激的脂解。此外,卡莫司他(0.1 - 100×10⁻⁶ M)不影响茶碱诱导的脂肪细胞半最大脂解。我们的研究结果不支持ε-胍基酸衍生物在休克中通过影响外周脂肪组织的脂解作用来减少血液中游离脂肪酸增加的观点。

相似文献

1
Influence of a low molecular weight serine proteinase inhibitor (camostate) on lipolysis of isolated adipocytes.一种低分子量丝氨酸蛋白酶抑制剂(抑肽酶)对分离脂肪细胞脂肪分解的影响。
Res Exp Med (Berl). 1985;185(6):503-7. doi: 10.1007/BF01851856.
2
Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro.小分子蛋白酶抑制剂甲磺酸加贝酯(FOY)对体外胰岛素受体功能的影响。
Int J Pancreatol. 1988 Mar;3(2-3):135-42. doi: 10.1007/BF02798924.
3
Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.低分子量丝氨酸蛋白酶抑制剂(卡莫司他)对离体胰腺腺泡淀粉酶释放的影响。
Res Exp Med (Berl). 1989;189(1):33-8. doi: 10.1007/BF01856026.
4
Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
Pancreas. 1987;2(2):164-9. doi: 10.1097/00006676-198703000-00007.
5
Elimination of the low-molecular weight proteinase inhibitor camostate (FOY 305) and its degradation products by the rat liver.
Res Exp Med (Berl). 1987;187(6):401-6. doi: 10.1007/BF01852177.
6
Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
Digestion. 1985;31(2-3):128-35. doi: 10.1159/000199189.
7
Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.一种特异性丝氨酸蛋白酶抑制剂对大鼠胰腺的作用:抑肽酶的全身给药与胰腺外分泌
Digestion. 1984;30(3):171-8. doi: 10.1159/000199102.
8
Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.卡莫司他(FOY - 305)可提高腹腔灌洗对牛磺胆酸盐诱导的胰腺炎的治疗效果。
Gut. 1990 Aug;31(8):934-7. doi: 10.1136/gut.31.8.934.
9
Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).饮食中的抑肽酶(FOY - 305)对大鼠胰腺中氮杂丝氨酸诱导结节生长的刺激作用。
Carcinogenesis. 1988 Jun;9(6):901-6. doi: 10.1093/carcin/9.6.901.
10
Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.鸟氨酸脱羧酶和多胺在卡莫司他(Foy - 305)诱导大鼠胰腺生长中的作用
Digestion. 1989;43(1-2):98-112. doi: 10.1159/000199867.

引用本文的文献

1
Influence of a small molecular weight proteinase inhibitor, gabexate mesilate (FOY), on insulin receptor function in vitro.小分子蛋白酶抑制剂甲磺酸加贝酯(FOY)对体外胰岛素受体功能的影响。
Int J Pancreatol. 1988 Mar;3(2-3):135-42. doi: 10.1007/BF02798924.